The founding team

KarMac was built by a multidisciplinary group of scientific inventors, expert oncologists, and engineers dedicated to solving one of the hardest challenges in cancer treatment. We are united by a shared mission to break down the biological barriers of solid tumors and unlock the body's natural immune response.

Rooted in deep myeloid biology, our leadership draws on extensive translational expertise from institutions like Harvard and Mount Sinai. By combining clinical insights with cutting-edge cellular engineering, the founding team is pioneering a completely new class of immuno-oncology therapies to bring transformative results to patients.